Copyright
©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 14, 2014; 20(6): 1594-1601
Published online Feb 14, 2014. doi: 10.3748/wjg.v20.i6.1594
Published online Feb 14, 2014. doi: 10.3748/wjg.v20.i6.1594
rSK (n = 110) | Phenylephrine (n = 110) | Total (n = 220) | |
Gender | |||
Male/female (% male) | 58/52 (52.7) | 66/44 (60.0) | 124/96 (56.4) |
Ethnicity | |||
White | 60 (54.5) | 56 (50.9) | 116 (52.7) |
Black | 13 (11.8) | 16 (14.5) | 29 (13.2) |
Mestizo | 37 (33.6) | 38 (34.5) | 75 (34.1) |
Age (yr) | |||
Median ± QR (range) | 46 ± 20 (18-74) | 45 ± 18 (21-75) | 45 ± 19 (18-75) |
Days from start of symptoms to treatment onset | |||
Median ± QR (range) | 3 ± 2 (0-26) | 3 ± 3 (0-38) | 3 ± 3 (0-38) |
Classification of the hemorrhoids | |||
External | 73 (66.4) | 73 (66.4) | 146 (66.4) |
Internal | 31 (28.2) | 30 (27.3) | 61 (27.7) |
Mixed | 6 (5.5) | 7 (6.4) | 13 (5.9) |
Grade of prolapse (I or II:III or IV) | (13:24) | (7:30) | (20:54) |
Presence of thrombosis | 59 (53.6) | 57 (51.8) | 116 (52.7) |
Debut of disease | 48 (43.6) | 44 (40.0) | 92 (41.8) |
Previous thrombectomy | 17 (15.5) | 16 (14.5) | 33 (15.0) |
Previous hemorrhoidectomy | 2 (1.8) | 1 (0.9) | 3 (1.4) |
-
Citation: Hernández-Bernal F, Castellanos-Sierra G, Valenzuela-Silva CM, Catasús-Álvarez KM, Valle-Cabrera R, Aguilera-Barreto A, Investigators PALSTT3GO. Recombinant streptokinase
vs phenylephrine-based suppositories in acute hemorrhoids, randomized, controlled trial (THERESA-3). World J Gastroenterol 2014; 20(6): 1594-1601 - URL: https://www.wjgnet.com/1007-9327/full/v20/i6/1594.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i6.1594